Is UnitedHealth Group Stock a Buy After Another Solid Quarter?

The past few years have been challenging ones for health insurance giant UnitedHealth Group (NYSE:UNH). Rising costs have been weighing on its results, and its five-year returns are in the red, with the stock declining by more than 5% during that stretch. That’s unusual for a stock that historically has generated terrific returns for investors.

The company, however, has been showing progress in recent earnings reports and in its latest one, once again showed improvements in its bottom line. The healthcare stock itself has also been picking up steam this year, as it’s up around 22% thus far in 2026. With another strong quarter in the books, has UnitedHealth Group done enough to prove that it’s a good buy again?

Missed Nvidia in 2009? This Rare Signal Is Flashing Again. In 2009, a “Double Down” signal flashed for a little-known chipmaker called Nvidia. For the first time in years, that same “Total Conviction” signal is flashing for a company 1/100th the size of Nvidia. Continue »

Three female medical staff work at computers behind a modern clinic reception desk.

Image source: Getty Images.

UnitedHealth exceeded expectations in Q3

Last week, UnitedHealth posted earnings that didn’t simply beat expectations; they soared past them. Its revenue for the quarter ending Sept. 30 totaled $112.7 billion, which was down from the prior-year period ($113.2 billion) but far higher than what analysts expected — $111.4 billion. Its adjusted earnings per share (EPS) of $4.69 was also higher than Wall Street’s expectations of $4.14.

In light of its improved results, the healthcare company also raised its guidance slightly, now expecting adjusted EPS to be at least $20.50 for the year, which is higher than its previous guidance, which ranged from $19.50 to $20. UnitedHealth has been able to achieve efficiencies by exiting markets that were unprofitable and also investing in artificial intelligence (AI).

Is UnitedHealth stock a cheap buy?

UnitedHealth stock closed at just over $401 last week as it gained momentum amid its strong earnings numbers. Given its sluggish performance in recent years, the stock remains fairly cheap with respect to earnings. Its forward price-to-earnings multiple is around 16, which is based on the level of profitability analysts project from the business in the year ahead. By comparison, the average S&P 500 stock trades at more than 19 times its estimated future profits.

For investors, it appears that UnitedHealth Group can still be an excellent long-term buy given its modest valuation and strong earnings results. It’s been heading in the right direction for multiple quarters, and it also offers an above-average dividend that yields 2.3%, making it an attractive option for income investors seeking a reliable payout.

Overall, UnitedHealth is a compelling option for investors seeking value, stability, and dividend income.

Should you buy stock in UnitedHealth Group right now?

Before you buy stock in UnitedHealth Group, consider this:

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and UnitedHealth Group wasn’t one of them. The 10 stocks that made the cut could produce monster returns in the coming years.

Consider when Netflix made this list on December 17, 2004… if you invested $1,000 at the time of our recommendation, you’d have $380,363!* Or when Nvidia made this list on April 15, 2005… if you invested $1,000 at the time of our recommendation, you’d have $1,315,732!*

Now, it’s worth noting Stock Advisor’s total average return is 919% — a market-crushing outperformance compared to 211% for the S&P 500. Don’t miss the latest top 10 list, available with Stock Advisor, and join an investing community built by individual investors for individual investors.

See the 10 stocks »

*Stock Advisor returns as of October 19, 2026.

David Jagielski, CPA has no position in any of the stocks mentioned. The Motley Fool recommends UnitedHealth Group. The Motley Fool has a disclosure policy.

Is UnitedHealth Group Stock a Buy After Another Solid Quarter? was originally published by The Motley Fool

Source link

Visited 1 times, 1 visit(s) today

Related Article

Gartner’s (IT) Medium-Term Growth Trajectory Remains Intact

Diamond Hill Capital, a First Eagle Investment Management company, issued its Q3 2026 investor letter for its “Large Cap Strategy”. The letter can be downloaded here. The Strategy returned 3.18% (net of fees) in the quarter, outperforming the 2.61% return of the Russell 1000 Value Index. Key positive contributors included stock selection in information technology, an underweight

I’ve Covered Netflix for 24 Years. Here’s Whether the Stock Is Overvalued Right Now.

I’m not one to typically celebrate investing anniversaries, but this month marks 24 years since I became a Netflix (NASDAQ: NFLX) shareholder. It’s been largely ups along the way, but lately there’s been a hard road down. Shares of the company behind the world’s leading premium streaming video service have plummeted more than 40% over

1 Large-Cap Stock to Research Further and 2 We Avoid

1 Large-Cap Stock to Research Further and 2 We Avoid Large-cap stocks usually command their industries because they have the scale to drive market trends. The flip side though is that their sheer size can limit growth as expanding further becomes an increasingly challenging task. This is precisely where StockStory comes in – our job

Prediction: This Will Be SpaceX’s Stock Price By the End of 2027

In June, Elon Musk’s space industrial giant, SpaceX (NASDAQ: SPCX), broke records with an initial public offering (IPO) that valued it at $1.77 trillion. This was the largest corporate debut in history, and it netted SpaceX $75 billion in capital that will be used to accelerate its burgeoning artificial intelligence (AI) and satellite internet businesses.

UK's hard-right Reform party hit by fresh scandal as racist views caught on camera

European stocks open in the red as French businesses count the cost of the riots

Stocks across Europe fell at the start of trading on Monday as France reeled from one of its most violent weekends in years, with shopkeepers and CEOs alike tallying the damage and accusing the authorities of leaving them exposed. ADVERTISEMENT ADVERTISEMENT The Euro Stoxx 50 only traded 0.1% lower but the broader pan-European Stoxx 600

Earnings To Watch: Halliburton (HAL) Reports Q3 Results Tomorrow

Earnings To Watch: Halliburton (HAL) Reports Q3 Results Tomorrow Oilfield services company Halliburton (NYSE:HAL) will be announcing earnings results this Tuesday before market open. Here’s what you need to know. Halliburton beat analysts’ revenue expectations last quarter, reporting revenues of $5.71 billion, up 3.7% year on year. It was a very strong quarter for the

RKLB Stock Suffers Worst Week Ever: AST SpaceMobile Partner Challenges Iridium Deal — Claims Rival Uses FCC To Block Competitors

AST SpaceMobile partner Ligado urged the FCC to scrutinize Rocket Lab’s proposed $8 billion Iridium acquisition. Ligado cited SpaceX’s allegation that Iridium filed more than 50 petitions to deny over eight months. Neutron’s debut has slipped into 2027, while the Iridium acquisition remains targeted for a mid-2027 close. Shares of Rocket Lab (RKLB) plunged over

Northrop Grumman (NOC) Q3 Earnings: What To Expect

Northrop Grumman (NOC) Q3 Earnings: What To Expect Security and aerospace company Northrop Grumman (NYSE:NOC) will be reporting results this Tuesday morning. Here’s what to expect. Northrop Grumman beat analysts’ revenue expectations last quarter, reporting revenues of $10.88 billion, up 5.1% year on year. It was a very strong quarter for the company, with full-year

ASTS Stock Jumps Overnight: Boost Mobile Founder Turns Buyer — Floats Potential Telecom Takeover For SpaceX Rival

Boost Mobile founder and MobileX CEO Peter Adderton said he is a buyer of AST SpaceMobile around $40, while acknowledging shares could fall further. His thesis centers on carriers avoiding dependence on a satellite provider that could become their biggest competitor. Adderton, however, retains concerns about AST SpaceMobile’s tech and standalone prospects. Boost Mobile founder

Japan’s Kioxia set for strong inflows on bigger Topix weighting, but margin selling looms

Delayed 12:26:16 2026-10-19 am EDT 5-day change 1st Jan Change 13,540.00 JPY +1.23% -10.80% +289.27% Published on 10/18/2026 at 11:16 pm EDT Reuters This article is reserved for our members. Log in to continue Log inCreate an account DurationAuto.2 months3 months6 months9 months1 year2 years5 years10 yearsMax. PeriodDayWeek Kioxia Holdings Corporation is a Japan-based company

Asian stocks start week on back foot, tracking tech-led Wall St losses

The losses in Asia tracked a tech-led selloff in New York on Friday (LEE HOON-KOO) Asian stocks mostly fell Monday as traders tracked a tech-heavy selloff on Wall Street that was fuelled by growing worries over the AI investment boom. Chipmakers and other firms linked to artificial intelligence were once again under pressure owing to

Here’s What a $10,000 Investment in Nvidia Stock Will Be Worth by 2030

Nvidia (NVDA -1.43%) has made investors significantly richer over the past four years, turning a $10,000 investment into nearly $179,000 as of this writing. This massive surge in Nvidia’s shares has been fueled by the advent of artificial intelligence (AI). When OpenAI’s ChatGPT, introduced publicly in November 2022, became a big hit, companies lined up

Anthropic IPO Buzz Has Investors Watching Nasdaq Stock And ECM Fee Winners

Anthropic’s push toward one of the biggest AI IPOs ever has put equity capital markets back under a bright spotlight, and investors do not want to be on the sidelines if underwriting fees and deal flow pick up around high profile listings. This article examines how that Anthropic news relates to three large U.S. investment

Updated Output Guidance Change The Bull Case For BP Stock (LSE:BP.)?

BP updated its third quarter 2026 production guidance, now expecting reported upstream output of 2,190 mboe/d to 2,240 mboe/d, split between Oil production & operations of 1,415 mboe/d to 1,445 mboe/d and Gas & low carbon energy of 775 mboe/d to 795 mboe/d. The more granular breakdown between oil operations and gas and low carbon

NVIDIA And 2 Other Fast Growing Stocks To Own

Inflation in the US hit 3.7% in September, driven by sharp jumps in energy costs, which puts profitable, financially sound growth stories in sharper focus for many investors. Companies that analysts expect to grow earnings quickly while still keeping their balance sheets in decent shape can look attractive when everyday costs feel higher. This article

What Has Changed For indie Semiconductor Since Its 66% Fall

indie Semiconductor has been busy, from reporting Q1 2026 revenue of US$55.5 million and a new US$25 million radar order to agreeing a €40 million CMOS sensor deal with ams OSRAM and launching the iND881 edge AI chip. For indie Semiconductor shareholders, the loss over the past year was 65.8%, including dividends. If you had

3 Canadian Growth Stocks With At Least 43% Earnings Growth

Accelerating US inflation, driven by sharp moves in energy prices, keeps pressure on interest rates and has made dependable earnings growth harder to find. That is where a group of financially solid Canadian growth stocks becomes interesting. According to analyst estimates, these companies are projected to increase profits over the next few years while maintaining

Trump’s Marijuana Order Is Stuck at the DEA. Here’s What That Means for Canopy Growth.

Last December, President Donald Trump issued Executive Order 14370, intended to fast-track the rescheduling of marijuana to Schedule III, in turn paving the way for federal regulatory clarity. At the time, marijuana stocks, including Canopy Growth (NASDAQ: CGC), surged sharply on the news, with Canopy itself surging from $1.15 to nearly $2 per share. Shares

0
Would love your thoughts, please comment.x
()
x